AMPICILLIN/SULBACTAM

Course overview

THE AMPICILLIN/SULBACTAM COMBINATION SHOWS SYNERGY TO COVER STRAINS OF BACTERIA RESISTANT TO AMPICILLIN, THUS PROVIDING BROADER COVERAGE. THIS COMBO ADDS A BETA-LACTAMASE INHIBITOR TO AMPICILLIN TO PROVIDE EXTENDED COVERAGE AGAINST POTENTIALLY RESISTANT BACTERIA. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT TO INTERPROFESSIONAL TEAM MEMBERS TO USE AMPICILLIN-SULBACTAM APPROPRIATELY FOR VARIOUS INDICATIONS WITH AN EYE TOWARDS ANTIMICROBIAL STEWARDSHIP.